查詢結果分析
相關文獻
- Papillary and Follicular Thyroid Carcinomas with Bone Metastases: A Series of 39 Cases during a Period of 18 Years
- 甲狀腺癌:概論與治療之最新發展
- 攝護腺癌的放射線治療及其護理
- 體外放射線對未經手術的視網膜母細胞瘤之治療效果: 回溯性研究報告
- 放射性碘與生育
- 骨骼轉移之放射治療
- Amiodarone引發甲狀腺毒症
- Minimally Invasive Endocrine Surgery: Laparoscopic Adrenalectomy, Videoscopic Parathyroidectomy and Beyond
- 骨骼轉移性腫瘤(metastatic tumors of skeleton)病理學診斷
- 癌症病患之症狀治療--以乳癌併骨骼轉移為例
頁籤選單縮合
題 名 | Papillary and Follicular Thyroid Carcinomas with Bone Metastases: A Series of 39 Cases during a Period of 18 Years=乳突型及濾泡型甲狀腺癌合併骨骼轉移:18年中39例病例研究 |
---|---|
作 者 | 范姜仁廣; 林仁德; 黃妙珠; 施信農; | 書刊名 | 長庚醫學 |
卷 期 | 21:4 1998.12[民87.12] |
頁 次 | 頁377-382 |
分類號 | 415.931 |
關鍵詞 | 乳突型及濾泡型甲狀腺癌; 骨骼轉移; 甲狀腺切除; 放射性碘; 體外放射線治療; Papillary and follicular thyroid carcinomas; Bone metastasis; Thyroidectomy; Radioactive iodine; External radiotherapy; |
語 文 | 英文(English) |
中文摘要 | 背景:在乳突型及濾泡型甲狀腺癌病人,骨骼轉移會導致死亡率增加。然而在台 灣,與乳突型及濾泡型甲狀腺癌合併骨骼轉移相關的臨床資料卻很有限。 方法:本文採回溯性分析統計林口長庚醫院近18年來的39例乳突型及濾泡型甲狀腺癌合併骨 骼轉移病人,以期明瞭其臨床表現及治療結果。 結果:乳突型及濾泡型甲狀腺癌的骨骼轉移發生率為4.3%,他們的平均年齡是57.5歲。28 位(71.8%)為濾泡癌,11位(28.2%)為乳突癌。女性佔32位(82%),男性佔7位(18%)。有 29例(74.4%),其甲狀腺癌的初始表現,是以骨骼轉移產生的症狀來表現。有33位病人其骨 骼轉移可在X光片上看見,而有28位之骨骼轉移可在I核醫掃描上偵測到。脊椎骨是最常被轉 移的骨骼(53.8%)。有31位病人(79.5%)其骨骼轉移為多發性。在治療過程中,有3人痊癒 ,而有14人死亡。以Kaplan-Meier方法所計算的5年存活率為64.9%。 結論:雖然骨骼轉移罕見於乳突型甲狀腺癌,但是對於濾泡型甲狀腺癌,骨骼轉移並非很罕 見。骨骼轉移常發生在年齡較大的病人,多發性骨骼轉移比單發性骨骼轉移常見。大部分的 病人是因骨骼被轉移所引起的症狀而開始求醫就診。即使大部分病人均接受合併療法,骨骼 轉移病人之預後仍然不佳。 |
英文摘要 | Background: Bone metastases can cause death in patients with papillary or follicular thyroid carcinoma. There is, however, limited information about the clinical presentations and prognoses of patients with papillary and follicular thyroid carcinomas with bone metastases in Taiwna. Materials and Methods: A series of 39 patients with papillary or follicular thyroid carcinomas with bone metastases treated at our center form 1977 through 1995 was retrospectively reviewed to elucidate the clinical presentations and results treatment of this disease. Results: The occurrence rate of bone metastasis in papillary or follicular thyroid carcinomas was 4.3%. Of the 39 patients, whose mean age was 57.5 years, 28(71.8%) had follicular and 11(28.2%) had papillary carcinomas. Thirty-two patients(82.1%) were female and 7(17.9%) were male. Twenty-nine patients (74.4%) presented with bone metastases before the thyroid cancers were diagnosed. Bone metastases were detected using radiography in 33 patients and using I scans in 28 patients. Thirty-one patients(79.5%) had multiple bone metastases. The spine was the most frequently involved site(53.8%). Three patients were disease-free and 14 patients died during the course of treatment. Using the Kaplan-Meier method, the 5-year survival rate was estimated to be 64.9%. Conclusion: Bone metastasis, although rate in patients with papillary carcinoma, was not very uncommon in patients with follicular carcinoma. Bone metastases occurred more often in older patients. Multiple bone metastases were noted more often than single bone metastasis. Most patients had symptoms and signs resulting from metastatic bone lesions. Although multimodality therapy was tried, the prognoses for most patients with bone metastases were poor. |
本系統中英文摘要資訊取自各篇刊載內容。